Urology Department Fondazione IRCCS Policlinico San Matteo
Pavia, 27100, Italy
NCT Number: NCT03790254
The aim of this review is to address clinical reliability, efficacy and safety of long-term treatment with oral D Mannose for the prevention of recurrent urinary tract infections (RUTIs) in females.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Pavia, 27100, Italy
A comprehensive systematic MEDLINE, Embase, Cochrane search was performed for English language reports published before December 2018 using the term "recurrent urinary tract infections and d mannose." We searched Medline, Embase, and the Cochrane Register of Controlled Trials since January 2010 to December 2018. Eligible studies did not include non-oral therapy, local (vaginal) treatment in women with RUTIs.
Study eligibility criteria- We identified eligible original articles. The heterogeneity of the available studies, their different rationale and aim, the assumption of d mannose for prophylaxis or treatment of recurrent UTIs need to be taken into account.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
recurrent urinary tract infections (RUTIs)
Exclusion criteria
Upper urinary tract infections, severe clinical symptoms, fever > 37,5 with lumbar pain
Time frame: January 2010-December 2018
literature search of the Medline, Embase, and Cochrane Library databases
Fondazione IRCCS Policlinico San Matteo di Pavia
Other
Oral D Mannose in the Prevention and Treatment of Recurrent Urinary Tract Infections: a Systematic Review
Acronym: mannoseRUTIs
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07627412
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Nanjing, Jiangsu, China
View Trial DetailsNCT02246270
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Tulsa, Oklahoma, United States
View Trial DetailsNCT01663181
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Vienna, Austria
View Trial DetailsNCT02869165
Atrophic Vaginitis, Female Urogenital Diseases
Louisville, Kentucky, United States
View Trial Details